T-cell polyfunctionality reconstitution after modified anti-thymocyte globulin plus post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation
Abstract
ObjectiveAnti-thymocyte globulin combined with post-transplant cyclophosphamide (ATG/PTCy) is increasingly used for graft-versus-host disease (GvHD) prophylaxis; however, functional immune reconstitution after this regimen remains insufficiently characterized. Conventional immune monitoring based on absolute cell counts may not adequately reflect immune competence.MethodsWe retrospectively analyzed 76 patients who received ATG/PTCy (ATG, 2.5 mg/kg/day on days −2 and −1; cyclophosphamide, 50 mg/kg on day +3) following allogeneic peripheral blood stem cell transplantation. Peripheral blood mononuclear cells collected on days +30, +60, +90, +180, and +360 were stimulated with Staphylococcal enterotoxin B (SEB), and T-cell functionality was assessed using COMPASS-derived functionality scores (FS) and polyfunctionality scores (PFS). Associations between immune reconstitution and acute GvHD (aGvHD), chronic GvHD (cGvHD), viral reactivation, and bloodstream infection were assessed.ResultsWithin 180 days after transplantation, 34.2% of patients developed aGvHD, including 25.0% with Grade II–IV aGvHD, and 61.8% experienced cytomegalovirus (CMV) reactivation. Peak CMV DNA loads >500 IU/mL were associated with higher incidence of aGvHD, Epstein–Barr virus (EBV) DNA detection, multiple viral infections, and bacteremia. Within 90 days, patients with Grade II–IV aGvHD showed lower CD4+ and CD8+ FS and PFS than those without Grade II–IV aGvHD. Higher CMV DNA levels were associated with impaired T-cell function at days +90 and +180. At day +60, a trend toward an interaction between aGvHD and CMV reactivation were observed for CD8+ T-cell function. At day +180, higher CD8+ T-cell counts and functional activity were associated with increased odds of cGvHD, whereas higher CD4+ T-cell and B-cell levels were associated with lower odds. By day +360, higher B-cell proportions remained inversely associated with cGvHD, whereas CD4+ T-cell levels showed no significant association.ConclusionsFunctional immune monitoring may complement immune cell enumeration and contribute to individualized post-transplant risk assessment in patients receiving ATG/PTCy-based allo-HSCT.
Related
- Kinetics of early immune reconstitution and its exploratory association with post-transplant outcomes in patients undergoing haploidentical HCT with post-transplant cyclophosphamide-based GvHD prophylaxis
- BCL10 deficiency: Long-term immune reconstitution following hematopoietic stem cell transplantation.
- Syngeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide to induce immune tolerance of allogenic skin graft survival in rat.
- Haploidentical and MHC-identical cells exhibit broadly similar immune reconstitution kinetics, with some compartment-specific differences, following hematopoietic cell transplantation in a murine model of severe combined immunodeficiency
- Hematopoietic cell transplantation using treosulfan-based conditioning for IL-10 receptor deficiency
BibTeX
@article{jiang2026tcell,
title = {{T-cell polyfunctionality reconstitution after modified anti-thymocyte globulin plus post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation}},
author = {Cen Jiang and Luxiang Wang and Lilan Jin and Yanying Gu and Minjing Mao and Yan Miao and Gang Cai},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1980998},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1980998},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - T-cell polyfunctionality reconstitution after modified anti-thymocyte globulin plus post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation
AU - Cen Jiang
AU - Luxiang Wang
AU - Lilan Jin
AU - Yanying Gu
AU - Minjing Mao
AU - Yan Miao
AU - Gang Cai
PY - 2026
DA - 2026/10/30
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1980998
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1980998
AB - ObjectiveAnti-thymocyte globulin combined with post-transplant cyclophosphamide (ATG/PTCy) is increasingly used for graft-versus-host disease (GvHD) prophylaxis; however, functional immune reconstitution after this regimen remains insufficiently characterized. Conventional immune monitoring based on absolute cell counts may not adequately reflect immune competence.MethodsWe retrospectively analyzed 76 patients who received ATG/PTCy (ATG, 2.5 mg/kg/day on days −2 and −1; cyclophosphamide, 50 mg/kg on day +3) following allogeneic peripheral blood stem cell transplantation. Peripheral blood mononuclear cells collected on days +30, +60, +90, +180, and +360 were stimulated with Staphylococcal enterotoxin B (SEB), and T-cell functionality was assessed using COMPASS-derived functionality scores (FS) and polyfunctionality scores (PFS). Associations between immune reconstitution and acute GvHD (aGvHD), chronic GvHD (cGvHD), viral reactivation, and bloodstream infection were assessed.ResultsWithin 180 days after transplantation, 34.2% of patients developed aGvHD, including 25.0% with Grade II–IV aGvHD, and 61.8% experienced cytomegalovirus (CMV) reactivation. Peak CMV DNA loads >500 IU/mL were associated with higher incidence of aGvHD, Epstein–Barr virus (EBV) DNA detection, multiple viral infections, and bacteremia. Within 90 days, patients with Grade II–IV aGvHD showed lower CD4+ and CD8+ FS and PFS than those without Grade II–IV aGvHD. Higher CMV DNA levels were associated with impaired T-cell function at days +90 and +180. At day +60, a trend toward an interaction between aGvHD and CMV reactivation were observed for CD8+ T-cell function. At day +180, higher CD8+ T-cell counts and functional activity were associated with increased odds of cGvHD, whereas higher CD4+ T-cell and B-cell levels were associated with lower odds. By day +360, higher B-cell proportions remained inversely associated with cGvHD, whereas CD4+ T-cell levels showed no significant association.ConclusionsFunctional immune monitoring may complement immune cell enumeration and contribute to individualized post-transplant risk assessment in patients receiving ATG/PTCy-based allo-HSCT.
SN - 1664-3224
ER -